JPMorgan Chase & Co. Issues Positive Forecast for U.S. Physical Therapy (NYSE:USPH) Stock Price

U.S. Physical Therapy (NYSE:USPH) had its price target boosted by equities researchers at JPMorgan Chase & Co. from $90.00 to $95.00 in a research report issued on Friday, Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 20.57% from the company’s previous close.

USPH has been the subject of a number of other research reports. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. Citizens Jmp reiterated a “market outperform” rating and set a $98.00 price objective on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Barrington Research raised their target price on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Zacks Research raised shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 27th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.25.

U.S. Physical Therapy Stock Up 1.4%

Shares of NYSE USPH traded up $1.08 during trading on Friday, reaching $78.79. The company had a trading volume of 72,260 shares, compared to its average volume of 208,788. U.S. Physical Therapy has a 12-month low of $58.19 and a 12-month high of $93.50. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.48. The business’s 50-day moving average is $76.93 and its 200 day moving average is $73.12. The stock has a market cap of $1.18 billion, a PE ratio of 463.50, a P/E/G ratio of 2.14 and a beta of 1.13.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.06). U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%.The business had revenue of $214.06 million during the quarter, compared to the consensus estimate of $211.36 million. During the same period in the previous year, the business posted $0.81 EPS. The firm’s revenue for the quarter was up 8.5% on a year-over-year basis. As a group, equities analysts forecast that U.S. Physical Therapy will post 2.95 earnings per share for the current fiscal year.

Institutional Trading of U.S. Physical Therapy

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Royal Bank of Canada raised its stake in U.S. Physical Therapy by 3.4% in the 1st quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock worth $5,733,000 after acquiring an additional 2,594 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in U.S. Physical Therapy by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock worth $644,000 after buying an additional 391 shares during the period. Jane Street Group LLC raised its position in U.S. Physical Therapy by 249.3% during the 1st quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock worth $3,568,000 after buying an additional 35,191 shares during the last quarter. Hsbc Holdings PLC purchased a new position in U.S. Physical Therapy during the 2nd quarter worth approximately $410,000. Finally, First Trust Advisors LP lifted its stake in U.S. Physical Therapy by 3.7% during the 2nd quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock valued at $839,000 after acquiring an additional 385 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.